slides · global inventory
Paragraph
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 118,471
Current window 17,941-17,970
Pages 3,950
Rows per page 30
Component
17,941-17,970 of 118,471
02
The slide uses the 'iceberg' metaphor to describe the hidden risks of the company's financial projections.Skillz, Inc. (SKLZ) · Wolfpack Research
Research note Short seller Beat · Villain Critique3 hits
11
Includes a Bloomberg terminal screenshot showing stock price movement and a snippet from an S-1 filing.Skillz, Inc. (SKLZ) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction3 hits
14
Includes specific references to legal case 'Cooper v. Skillz, Inc.' and footnotes.Skillz, Inc. (SKLZ) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction3 hits
107
The slide uses Q&A transcripts to build a narrative of 'organ trafficking' or unethical donor selection.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 3 hits
125
The slide uses a legal statute to frame the company's business model as criminal activity.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 3 hits
145
The slide uses a Q&A format to present testimony from an industry veteran, highlighting allegations of unethical sales practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 3 hits
162
The slide uses a Q&A format to present expert testimony regarding potential misuse of medical devices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 3 hits
178
The slide uses expert quotes to argue that off-label use of perfusion pumps is limited by reputational risk and biological constraints.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 3 hits
203
The slide uses a Q&A format to present qualitative feedback from an industry expert.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 3 hits
206
The slide uses direct quotes and interview transcripts to build a case of professional negligence or strategic malpractice.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 3 hits
251
The slide uses highlighted text to emphasize key grievances (dishonesty, forced bundling, anger).TransMedics (TMDX) · Scorpion Capital
Research note Short seller 3 hits
254
The slide uses direct quotes from former employees and industry contacts to build a negative narrative around the CEO's personality and professional standing.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 3 hits
274
The slide uses Q&A transcripts to highlight a shift away from OCS technology in high-volume transplant centers.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 3 hits
279
The slide uses direct quotes from an UCSF administrator to build a case against TransMedics' long-term viability at the institution.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 3 hits
286
The slide uses a Q&A format to highlight the gap between the device's intended utility and real-world clinical experience.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 3 hits
292
The slide uses highlighted text to emphasize key negative claims from a surgeon.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 3 hits
299
The slide presents a synthesis of expert commentary followed by verbatim Q&A excerpts highlighting the 'last resort' nature of the current service and the future growth thesis.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 3 hits
300
The slide uses direct quotes from surgeons and an ex-employee to build a case against the viability of the NOP service for heart transplants.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 3 hits
334
The slide uses a combination of narrative summary and direct Q&A excerpts to build a case against the company's product claims.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 3 hits
14
The slide uses anecdotal evidence from customers, ex-employees, and competitors to build a case against the company's operational viability.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Beat · Exposing contradictions in Twist's narrative3 hits
20
The slide uses numbered points to build a case against the company's long-term viability.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Beat · Exposing contradictions in Twist's narrative3 hits
25
The slide uses aggressive, emotive language ('dumpster fire', 'spectacle', 'circus') typical of activist short-seller reports.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Beat · Critique of Twist's management and strategy3 hits
27
The slide uses a highly aggressive, polemical tone to frame the company as a failing entity.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Beat · Critique of Twist's management and strategy3 hits
52
The slide uses a Q&A format and direct quotes to build a narrative of intellectual property theft and business model failure.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 3 hits
54
The slide uses a Q&A format to validate the thesis that the technology is fundamentally flawed.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 3 hits
70
Uses expert quotes to highlight the discrepancy between Twist's pricing and the actual cost of manufacturing.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Beat · Presentation of the thesis3 hits
71
Uses Q&A format to present primary source interview data.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 3 hits
78
The slide uses a Q&A format to highlight a contradiction between the company's claims and the operational reality described by a former employee.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 3 hits
87
The slide uses highlighted text to emphasize key criticisms regarding development time, labor intensity, and error rates.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 3 hits
115
Uses historical precedent of WorldCom fraud to frame current allegations against Twist.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 3 hits